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Background: The number of cancer patients and the number of patients surviving initial treatments is expected to
rise. Traditionally, follow-up monitoring takes place in secondary care. The contribution of general practice is less
visible and not clearly defined.
This study aimed to compare healthcare use in general practice of patients with cancer during the follow-up phase
compared with patients without cancer. We also examined the influence of comorbid conditions on healthcare
utilisation by these patients in general practice.
Methods: We compared health care use of N=8,703 cancer patients with an age and gender-matched control
group of patients without cancer from the same practice. Data originate from the Netherlands Information Network
of General Practice (LINH), a representative network consisting of 92 general practices with 350,000 enlisted
patients. Health care utilisation was assessed using data on contacts with general practice, prescription and referral
rates recorded between 1/1/2001 and 31/12/2007. The existence of additional comorbid chronic conditions
(ICPC coded) was taken into account.
Results: Compared to matched controls, cancer patients had more contacts with their GP-practice
(19.5 vs. 11.9, p<.01), more consultations with the GP (3.5 vs. 2.7, p<.01), more home visits (1.6 vs. 0.4, p<.01) and
they got more medicines prescribed (18.7 vs. 11.6, p<.01) during the follow-up phase. Cancer patients more often
had a chronic condition than their matched controls (52% vs. 44%, p<.01). Having a chronic condition increased
health care use for both patients with and without cancer. Cancer patients with a comorbid condition had the
highest health care use.
Conclusion: We found that cancer patients in the follow-up phase consulted general practice more often and
suffered more often from comorbid chronic conditions, compared to patients without cancer. It is expected that
the number of cancer patients will rise in the years to come and that primary health care professionals will be more
involved in follow-up care. Care for comorbid chronic conditions, communication between specialists and GPs, and
coordination of tasks then need special attention.
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Figure 1 Number of patients with cancer by gender and age
group (absolute numbers; males n=3800, females n=4903).
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In general, cancer is a disease of the old age. Highest
prevalence rates of almost all cancers are found among
persons older than 55 years of age. For example, while
this age group comprises only 20% of the population in
the United States, over 80% of the invasive cancers are
found in this group [1]. Therefore, with an ageing popu-
lation (for figures of the Netherlands see [2]), it is
expected that the number of cancer patients will in-
crease substantially. Diagnosis, initial treatment of can-
cer and follow-up care is for the larger part provided by
specialists working in secondary care [3,4]. With an in-
creasing number of patients with cancer and an increas-
ing number of cancer patients surviving for a longer
period of time a reorganization of health care will be
necessary. New roles for general practitioners (GPs) and
other primary care professionals in cancer care might
emerge, for example in follow-up care.
Anticipating these future developments, it is interest-
ing to know what care is currently delivered to cancer
patients by GPs. In literature, few studies are found
which focus on health care use of cancer survivors in
primary care. Roorda et al. [5] reported higher health
care utilisation rates in general practice for breast cancer
patients during the year after diagnosis compared to the
control group. This is in line with the results of a British
study [6]: the year after their diagnosis of breast cancer
the contact rate of patients with their GP more than
doubled compared to the year preceding their diagnosis.
Two years after their diagnosis, the contact rate had not
yet returned to the baseline level. In a group of long-
term survivors of Hodgkin's disease, French researchers
found a slight increase in the number of visits to a gen-
eral practitioner compared to matched control patients
[7]. A study that did not match these results concluded
that the consultation rates of cancer patients in general
practice did not increase when GPs took care for dis-
charged long-term cancer survivors [8]. However, these
patients were voluntarily discharged from secondary care
and might not be a representative sample of long-term
cancer survivors.
We studied health care use in general practice of
patients with cancer during the follow-up phase. Did
they use more health care in general practice, compared
to patients without cancer? Because many cancer
patients are older than 65 years, we also focussed on the
presence of comorbid chronic conditions and whether
these conditions influenced health care use in general
practice.
Methods
Design
To analyse health care use of cancer patients in general
practice we used routinely collected data from theNetherlands Information Network of General Practice
(LINH). We compared the health care use of cancer
patients during the follow-up phase with age and gender
matched control patients from the same practice in a
retrospective cohort study.
General practices
The Netherlands Information Network of General Prac-
tice (LINH) is a representative network consisting of 92
general practices from all over the Netherlands with
about 350,000 enlisted patients. In the Netherlands,
every inhabitant is listed with a general practitioner. The
LINH database holds longitudinal data on GP care, in-
cluding patient contacts, referrals, prescription medi-
cines, and relevant health problems. Health problems
are coded by the GP, using the International Classifica-
tion of Primary Care (ICPC) [9]. The database is used
for health services research and quality of care research.
For more information on the network see www.linh.nl.
Patients and controls
Based on ICPC-codes [see paragraph below] we selected
all patients for whom a diagnosis of cancer was recorded
between January 1, 2001 and December 31, 2007. This
resulted in 8,703 cancer patients, 44% males and 56%
females for whom health care data were available on a
minimum of 30 days during the follow-up phase (see
further). The age distribution of the cancer patients is
shown in Figure 1.
Cancer patients were matched for age (in five year
intervals) and gender with patients without a diagnosis
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could include 8,672 control patients (data not shown).
Type of cancer
For 69.2% of all selected patients with cancer (N=8,703)
one of the following cancer types was recorded: breast
cancer (ICPC code X76, 27.7% of all patients), colon/
rectal cancer (D75, 13.6% of all patients), prostate cancer
(Y77, 13.5% of all patients), lung/bronchus cancer (R84,
9.3% of all patients) and cancer of the bladder (U76, 5.1%
of all patients).
For 70.0% of the female patients with cancer
(N=4,903) one of the following cancer types was
recorded: breast cancer (X76, 49.3% of the women),
colon/rectal cancer (D75, 11.8% of the women), and ma-
lignancies of female reproductive organs (X77, 8.9% of
the women).
For 61.2% of the male patients with cancer (N=3,800)
one of the following cancer types was recorded: prostate
cancer (Y77, 30.9% of the men), colon/rectum cancer
(D75, 15.8% of the men) and lung/bronchus cancer
(R84, 14.4% of the men).
Other cancer types with low numbers of patients
included the following ICPC coded cancer types: A79
(malignancy not otherwise specified (NOS)), B72 (Hodg-
kin's disease/lymphoma), B73 (leukaemia), B74 (malig-
nant neoplasm blood other), D74 (malignant neoplasm
stomach), D76 (malignant neoplasm pancreas), D77
(malignant neoplasm digestive system other/NOS), N74
(malignant neoplasm nervous system), R85 (other malig-
nant neoplasm respiratory), S77 (malignant neoplasm of
the skin, excluding squamous and basal cell carcinoma),
T71 (malignant neoplasm thyroid), U75 (malignant neo-
plasm of kidney), U77 (malignant neoplasm urinary
other), W72 (malignant neoplasm related to pregnancy),
X75 (malignant neoplasm cervix uteri), Y78 (malignant
neoplasm male genital other).
Follow-up phase and observation period
We studied use of health care in general practice of can-
cer patients during the follow-up phase. We defined this
phase as starting after the end of the initial treatment
and ending before the terminal phase started. Both the
initial treatment phase and the terminal phase were
excluded, because during these periods patients might
have special health care needs that are not representative
for the remainder of this period. We set the end of initial
treatment to be six months after the first recording of
the diagnosis in the electronic medical record (EMR) in
the practice and the start of the terminal phase on three
months before death or the last registration in the EMR.
For reasons of reliability we included only those patients
of whom an observation period of at least 30 days was
available.All health care data recorded in the EMR between
January 1, 2001 and December 31, 2007 were included
in the analyses. Of all patients 78% was still alive at the
end of the observation period, 17% had died, and 5% of
the patients left the practice because they moved. The
length of the observation period differs for every patient,
depending on the date of diagnosis. For the most fre-
quently represented types of cancer we found the follow-
ing median lengths of the observation period: breast
cancer (X76) 644 days, colon/rectal cancer (D75)
556 days, prostate cancer (Y77) 598 days, lung/bronchial
cancer (R84) 432 days, and cancer of the bladder (U76)
612 days.
Comorbid chronic conditions
For every patient the presence of comorbid chronic con-
ditions was determined using ICPC coded diagnoses
recorded during contacts, prescriptions or referrals. We
used the classification for comorbid chronic conditions
as described by Knottnerus et al. [10]: sensory conditions
(including ear and eye conditions), heart disease, muscu-
loskeletal system, neurological-movement conditions,
neurological-pain conditions, psychiatric conditions, re-
spiratory conditions, skin conditions, endocrinological
conditions, and urogenital conditions.
Health care use
The EMR encompasses routinely recorded data for every
patient enlisted in the practice, including contacts with
the practice, morbidity, referrals to other health care
providers and drugs prescribed. The total number of
contacts with general practice includes face to face con-
sultations with the GP, home visits, telephone contacts
for prescriptions, vaccinations, email contacts, and ad-
ministrative activities. For all data recorded during the
observation period numbers were recalculated to a one
year’s period.
In the Netherlands the GP functions as the ‘gate-
keeper’ of care, meaning that patients need a referral for
specialist health care or for other primary health care
workers [11]. The number of referrals can be seen as an
indication of the ability of GPs to deal with requests for
treatment themselves. We calculated the mean number
of new referrals per patient per year.
Analyses
Cancer patients were compared with age- and gender-
matched control patients with regard to the number of
contacts with general practice, diagnoses of comorbid
conditions, rate of prescribing, and the referral rate in a
year.
Furthermore, we studied the influence of having a
comorbid chronic condition on health care use. The
group of cancer patients without comorbid chronic
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group without comorbid chronic conditions while the
group of cancer patients with comorbid chronic condi-
tions was compared with the matched control group
with comorbid chronic conditions.
We calculated mean figures for the number of con-
tacts with the practice, prescriptions and referrals, and
tested for statistical significance of the differences be-
tween the two groups using univariate variance analyses
(Student’s t-test). Because of our large sample size, p=0. 01
was set as cut-off value for statistical significance.
Results
Health care use in general practice
During the period observed, cancer patients used more
care in general practice as compared to matched con-
trols without cancer (Table 1). They had more contacts
in the general practice in a year, a higher number of face
to face consultations with the GP, more home visits,
more prescriptions, and more referrals to secondary spe-
cialist care.
The higher health care use of cancer patients was
found both in males and in females (Table 2). Health
care use of cancer patients older than 30 years of age
was higher compared to the matched control group.
However, cancer patients younger than 30 years of age
did not differ from age-matched controls in the number
of face to face consultations with the GP, the number of
home visits and referrals. But compared to the control
group they did have a higher total number of contacts
with the general practice, caused by more telephone
contacts and/or, email contacts and/or administrative ac-
tivities in the electronic medical record.
Health care use and comorbid chronic conditions
The percentage of patients with at least one comorbid
chronic condition was higher amongst the group of can-
cer patients compared to their matched controls
(Table 3). This accounts for both men and women, but
not for patients younger than 30 years of age.Table 1 Health care use of cancer patients (n=8,703)
compared to matched controls (n=8,672) (mean number
and standard error of the mean (SEm) of contacts,
prescriptions and referrals per patient in a year)
cancer patients
(mean and (SEm))
patients without
cancer
(mean and (SEm))
contacts with general practice 19.5 (.2)* 11.9 (.1)
- face to face consultations 3.5 (.05)* 2.7 (.04)
- home visits 1.6 (.06)* .40 (.02)
prescriptions 18.7 (.2)* 11.6 (.2)
referrals 0.56 (.1)* 0.42 (.1)
* difference between cancer patients and patients without cancer: p<0.01.Compared to the matched control group, GPs recorded
heart disease, psychological, respiratory, skin and urogeni-
tal problems more often for cancer patients (Table 4).
Endocrinological problems, amongst which diabetes, were
the most frequent problems but they are not more fre-
quently recorded in cancer patients than in the matched
control patients.
We split both groups (patients with and without cancer)
in two according to the presence of comorbid chronic
conditions (Table 5). Having cancer is related to signifi-
cantly more health care use in general practice, irrespect-
ive of having a comorbid chronic condition. Patients with
both cancer and a comorbid chronic condition have the
highest use of care in general practice.
Discussion
Use of care in general practice
We found that during the follow-up phase cancer
patients have double the use of health care services in
general practice compared to controls. This included
face to face contacts with GPs, home visits, prescribed
medication and referrals to secondary specialist’s care. In
the period after the end of initial treatment and before
the start of the terminal phase, patients with cancer have
more contacts with the general practice, amongst which
more face to face consultations with the GP, more home
visits, more prescriptions and they are more often re-
ferred to secondary care. They have more often one or
more comorbid chronic conditions, amongst which
heart, psychological, respiratory, skin and urogenital pro-
blems. Having a comorbid chronic condition further
increases health care use in general practice.
In the literature, the few studies describing primary
health care use of cancer patients report conflicting
results [5-8,12,13]. One of the reasons is that health care
systems and accessibility of secondary care differs be-
tween countries. Our study gives evidence that in the
Dutch gatekeeper system, general practice has a substan-
tial role in delivering care to cancer patients. This is in
line with Roorda et al. [5] who reported more face to
face contacts of breast cancer patients with GPs, more
drug prescriptions and more referrals to secondary care
during the year after the diagnosis compared to the year
preceding the diagnosis.
Comorbidity
Patients with both cancer and comorbid chronic con-
ditions have the highest health care use in general
practice. Comparable results were reported by Kurtz
et al. [14] in the United States who found that use of
primary care physicians' services depended substan-
tially on comorbid conditions. Koroukian et al. [15]
also reported that the complexity of health care de-
mand increases when patients have cancer plus
Table 2 Health care use of cancer patients by gender and age group (n=8,703) (mean number of contacts,
prescriptions and referrals per patient in a year)
gender age group (year)
male female ≤ 14 15-29 30-44 45-59 60-74 75+
contacts with general practice 20.0* 19.1* 10.3* 8.9* 12.5* 16.3* 20.4* 25.4*
- face to face consultations 3.6* 3.4* 1.8 1.7 2.7* 3.2* 4.0* 3.5*
- home visits 1.8* 1.5* 0.8 0.1 0.4* 0.9* 1.5* 3.1*
prescriptions 19.5* 18.0* 5.1* 5.5* 8.5* 13.6* 19.7* 27.8*
referrals 0.50* 0.60* 0.27 0.26 0.52* 0.48* 0.60* 0.62*
* health care use of cancer patients is significantly higher compared to the health care use of the gender- and age-matched control group without cancer (figures
of the control group not shown; p<0.01).
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and/or geriatric syndromes. De Bock et al. [16]
reported an increased prescription of psychotropic
medication for female breast cancer patients on endo-
crine therapy. Anti-depressants were only prescribed
during a short period, but anxiolytics, hypnotics and
sedatives were prescribed for a much longer period.
These data indicate increased psychological distress
due to breast cancer diagnosis and/or treatment in
women on endocrine therapy.
Several authors report that cancer survivors do not
seem to receive the same quality of care for their
comorbid conditions compared to the general popula-
tion [12]. Examples are diabetes care [17], cardiopul-
monary rehabilitation programs [18] or outpatient
management of antithrombotic treatment [19,20].
Health care professionals seem to be more focused
on cancer-related care compared to non-cancer
related health care needs. Given the increase in the
number of older patients who have more comorbid
chronic conditions, this is a point of attention.Table 3 Percentage of cancer patients (n=8,703) and
patients without cancer (n=8,672) with at least one
comorbid chronic condition
cancer patients (%) patients without
cancer (%)
- all 51.9* 44.5
- male 52.0* 43.9
- female 51.8* 44.9
Age group
- ≤ 14 year 22.5 12.5
- 15–29 year 19.3 17.0
- 30–44 year 31.4* 24.2
- 45–59 year 42.1* 34.0
- 60–74 year 56.3* 50.2
- 75+ year 66.6* 58.1
* difference between cancer patients and patients without cancer: p<0.01.Follow-up cancer care by GPs
We found that, in the Netherlands, health care use by
cancer patients in general practice is quite substantial. It
is expected that the role of GPs will increase further in
the future. Cancer follow-up care is recognized inter-
nationally as a pressing health care issue. The number of
patients is increasing, causing more strain on specialized
in-hospital care. The benefit of follow-up in secondary
care is questioned [21]. A more prominent role of GPs
in follow-up care might come of help.
What do patients think of such a role for the GP?
Patients often developed strong relationships with the
specialist and staff members like nurses in the hospital
during their treatment [22,23]. They hold the opinion
that their GP is not sufficiently informed about their dis-
ease and treatment, and they did not want to bother
their GPs with complaints [22]. However, Norwegian
researchers found that both GPs and cancer patients
valued the role of the GP in shared follow-up care as
long as the specialist is easily accessible [24]. In severalTable 4 Percentage of cancer patients (n=8,703) and
patients without cancer (n=8,672) with a comorbid
chronic condition
cancer patients (%) patients without
cancer (%)
Clusters of conditions:
- sensory (including ear and eye) 1 1
- heart disease 19* 16
- musculoskeletal system 12 11
- neurological-movement 2 1
- neurological-pain 2 2
- psychological 10* 7
- respiratory 10* 8
- skin 8* 5
- endocrinological 21 19
- urogenital 6* 4
* difference between cancer patients and patients without cancer: p<0.01.
Table 5 Health care use of cancer patients and patients without cancer by the presence of a comorbid chronic
condition (mean number of contacts, prescriptions and referrals per patient in a year)
No chronic condition One or more chronic conditions
cancer patients
(n=4,190)
patients without
cancer (n=4,816)
cancer patients
(n=4,513)
patients without
cancer (n=3,856)
contacts per year 14.4* 7.1 24.3* 18.0
- face to face consultations per year 2.6* 1.8 4.3* 4.0
- home visits per year 1.3* 0.2 2.0* 0.7
prescriptions per year 12.0* 5.6 24.9* 19.1
referrals per year 0.4* 0.2 0.7* 0.6
* difference between cancer patients and patients without cancer : p<0.01.
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ondary care professionals in delivering follow-up care,
so-called ‘shared care’. These initiatives can have differ-
ent formats: from a scheduled consultation with the GP
following the initial treatment [25] to a ‘shared care’ pro-
gram in which specialists communicate extensively with
GPs after discharge of the patient from the hospital and
patients are stimulated to contact their GP in case of
questions and problems [26]. To facilitate follow-up care
for both GPs and patients a web-based survivor care
plan might be used, including data on diagnosis, treat-
ment and potential risks as well as recommendations for
follow-up. In a recent study, such a web-based survivor
care plan was positively evaluated by both patients and
GPs [27].
Communication between specialist and GP is reported
regularly as a major problem for the GP in delivering ad-
equate care [28,29]. Standard information supplied by the
specialist is often insufficient or too late. The coordination
of patient care and communication between GPs and can-
cer specialists was found to improve when GPs are able to
consult the electronic medical record of the specialist
[30,31]. Furthermore, the development of guidelines, de-
scribing tasks and coordination in follow-up care for both
specialists and GPs is of utmost importance [21].
Limitations of the study
Because most patients are diagnosed with cancer in sec-
ondary care, the exact date of diagnosis is not always
recorded appropriately in the EMR of the GP, neither is
the date of the end (or start) of treatment. Therefore, we
had to estimate the start of the follow-up phase: six
months after the first recording of the diagnosis of can-
cer in the EMR. The date of the end of the observation
period due to death or other reasons is registered accur-
ately in the EMR, so we could exclude the terminal
phase. The majority of cancer patients studied was still
alive at the end of the study period. These facts com-
bined, mean that the length of the follow-up phase stud-
ied differed for the cancer patients depending on time of
inclusion, date of death or end of the study period.Conclusion
We found that cancer patients in the follow-up phase
had higher health care utilisation in general practice
compared to patients without cancer. It is expected that
primary health care professionals will be involved even
more in follow-up care for cancer patients in the future.
When shifting the balance of follow-up care to general
practice, attention is needed for the fact that many can-
cer patients have comorbid chronic conditions that need
special attention. Consideration is then needed for co-
ordination of tasks and communication between specia-
lists and GPs.
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